Source: International Congress 2015 – Therapeutic approaches in inflammatory lung disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Usman Farkhutdinov (Ufa, Republic of Bashkortostan, Russian Federation), Usman Farkhutdinov, Shamil Farkhutdinov. Antioxidant efficiency in the treatment of asthma exacerbations. Eur Respir J 2015; 46: Suppl. 59, 3890

Member's Comments

No comment yet.

Related content which might interest you: Serious asthma exacerbations in a hospital setting Source: International Congress 2014 – Asthma: clinical problems Year: 2014 Use of β-blockers and the risk of asthma exacerbations Source: International Congress 2016 – Asthma: from basic mechanisms to novel therapeutic perspectives Year: 2016 Study of antioxidant use in patients with asthma exacerbations Source: Annual Congress 2013 –Asthma drugs: new findings Year: 2013 Clinical effectiveness of anti-IgE therapy in allergic severe asthma Source: International Congress 2014 – Asthma and COPD management Year: 2014 Morphofunctional study of bronchial asthma with extrahospital pneumonia Source: International Congress 2014 – Biomarkers of asthma and clinical immunology Year: 2014 Characteristics of the adult corticosteroid-dependent severe asthma in UBIOPRED consortium Source: International Congress 2014 – Novel targets and drugs for asthma and COPD Year: 2014 Outcomes of immunotherapy of patients with COPD Source: International Congress 2014 – Intervening in allergic asthma Year: 2014 Acute exacerbations of asthma in Barcelona, the recent experience Source: Annual Congress 2013 –Epidemiology of asthma Year: 2013 P-PiXel: A ’real-life’ evaluation of omalizumab use in asthmatic patients Source: International Congress 2016 – Asthma management Year: 2016 Evaluating omalizumab persistency of response after long-term therapy (XPORT) Source: International Congress 2014 – Intervening in allergic asthma Year: 2014 The impact of bacterial lysate on asthma prevention in mouse and its mechanism Source: International Congress 2014 – Paediatric asthma: markers and molecules Year: 2014 When needed use of inhaled steroids in children with asthma Source: International Congress 2014 – Paediatric asthma: pharmacological and non-pharmacological management Year: 2014 Applying the 3Rs to asthma research Source: International Congress 2015 – Immune aspects of asthma and other airway diseases Year: 2015 Experience with omalizumab in patients with moderate and severe asthma Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments Year: 2014 Pharmacogenetics in severity of bronchial hyperresponsiveness in asthma Source: Annual Congress 2013 –Genetic factors in airway development and disease Year: 2013 Predictors of exacerbations in asthma Source: International Congress 2015 – Clinical assessment in asthma and COPD Year: 2015 Combined therapy of asthma and allergic rhinitis Source: Annual Congress 2013 –Treatment of asthma Year: 2013 Guideline adherence and cost of asthma treatment at emergency department Source: International Congress 2014 – Paediatric asthma: pharmacological and non-pharmacological management Year: 2014 Total and free IgE in evolution of severe asthma after omalizumab treatment Source: International Congress 2016 – Asthma management Year: 2016 Chronic dosing effects of propranolol in asthma Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings Year: 2013